Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
8
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
97
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Oneview Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Digital Patient Engagement And Cloud SaaS Will Expand Healthcare Reach
Key Takeaways Rapid uptake of digital engagement solutions and key partnerships are expanding market reach, recurring revenue, and operational leverage, strengthening growth prospects. Innovative product launches and a successful "land and expand" model are boosting upsell opportunities, customer retention, and gross margins, supporting long-term profitability.
View narrative
AU$0.42
FV
42.1% undervalued
intrinsic discount
38.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Deezer
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Emerging Digital Trends Will Unlock Global Streaming Potential
Key Takeaways Diversification into high-margin B2B solutions and partnerships with providers is driving revenue growth, margin improvement, and earnings quality. Cost reductions, marketing efficiency, and AI-led innovation are boosting profitability, retention, and differentiation in a competitive streaming market.
View narrative
€1.87
FV
35.2% undervalued
intrinsic discount
14.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Anaergia
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Capital Sales And Global Partnerships Will Create New Opportunities
Key Takeaways Transition to a capital-light model and strong focus on capital sales increases backlog, positively impacting future revenue and earnings. Strategic partnerships and expansion projects in Italy and Japan, backed by incentives, enhance capacity, technology, and competitive advantage.
View narrative
CA$1.30
FV
3.1% overvalued
intrinsic discount
20.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
SoundThinking
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
ShotSpotter Deployments And SafePointe Implementation Will Unlock New Markets
Key Takeaways International expansion and legislative mandates are key drivers of revenue growth, with potential significant impacts on top-line revenue and revenue streams. Technological integration and resource adoption enhance operational efficiency and margins, while potential Chicago reengagement could significantly boost earnings.
View narrative
US$22.17
FV
48.5% undervalued
intrinsic discount
8.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Gruvaktiebolaget Viscaria
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Exploration And Permits Will Drive Copper Mine Efficiency
Key Takeaways Recent exploration success and increased mineral resources enhance future revenue potential and cost-efficiency, likely improving margins and profitability. Legal permit acquisition and strategic partnerships enable uninterrupted development activities, driving revenue growth and better operational execution.
View narrative
SEK 40.00
FV
60.4% undervalued
intrinsic discount
55.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Gossamer Bio
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Phase III Trials And Global Collaborations Will Expand Treatment Horizons
Key Takeaways Successful Phase III study enrollment and collaboration enhance market reach, promising revenue growth through potential positive efficacy results and expanded indications. Anticipated first-in-class status and expanded dosing strategies could drive market adoption and earnings through competitive positioning and a broader patient base.
View narrative
US$8.16
FV
78.4% undervalued
intrinsic discount
65.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
3 days ago
author updated this narrative
Lanvin Group Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Operational Hurdles And Brand Shifts Will Reshape Luxury Market Appeal
Key Takeaways Revenue decline due to saturated luxury markets and creative transitions may hinder revenue growth and market positioning. Operational inefficiencies and economic uncertainties could impact net margins and delay profitability, affecting earnings projections.
View narrative
US$1.50
FV
45.1% overvalued
intrinsic discount
10.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Healwell AI
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Acquisition Will Create A Unified Global Healthcare Platform
Key Takeaways The acquisition of Orion Health is expected to boost Healwell AI's international presence and revenue growth through enhanced data infrastructure and operational synergies. Strategic leadership changes and a focus on operational excellence are anticipated to drive sustainable profitability and improved long-term financial health.
View narrative
CA$3.45
FV
58.8% undervalued
intrinsic discount
70.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
3 days ago
author updated this narrative
Evolv Technologies Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
AI Screening Will Expand Public Safety Applications
Key Takeaways Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets. Transition to a subscription model increases earnings visibility and profitability, supported by high customer retention and expanding existing accounts.
View narrative
US$7.19
FV
1.4% overvalued
intrinsic discount
17.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies